Literature DB >> 10381527

Identification of a defect in the intracellular trafficking of a Kell blood group variant.

K Yazdanbakhsh1, S Lee, Q Yu, M E Reid.   

Abstract

Blood group polymorphisms have been used as tools to study the architecture of the red blood cell (RBC) membrane. Some blood group variants have reduced antigen expression at the cell surface. Understanding the underlying mechanism for this reduced expression can potentially provide structural information and help to elucidate protein trafficking pathways of membrane proteins. The Kp(a+) phenotype is a variant in the Kell blood group system that is associated with a single amino acid substitution (R281W) in the Kell glycoprotein and serologically associated with a weakened expression of other Kell system antigens by an unknown mechanism. We found by immunoblotting of RBCs that the weakening of Kell antigens in this variant is due to a reduced amount of total Kell glycoprotein at the cell surface rather than to the inaccessibility of the antigens to Kell antibodies. Using a heterologous expression system, we demonstrate that the Kpa mutation causes retention of most of the Kell glycoprotein in a pre-Golgi compartment due to differential processing, thereby suggesting aberrant transport of the Kell protein to the cell surface. Furthermore, we demonstrated that single nucleotide substitutions into the coding region of the common KEL allele, as predicted by the molecular genotyping studies, was sufficient to encode three clinically significant low incidence antigens. We found that two low incidence antigens can be expressed on a single Kell protein, thus showing that the historical failure to detect such a variant is not due to structural constraints in the Kell protein. These studies demonstrate the power of studying the molecular mechanisms of blood group variants for elucidating the intracellular transport pathways of membrane proteins and the requirements for cell surface expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381527

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expression.

Authors:  H D Moulding; R L Martuza; S D Rabkin
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

2.  Sequence-Based Typing of Human Blood Groups.

Authors:  Axel Seltsam; Andrea Doescher
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

3.  Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.

Authors:  Randall W Velliquette; Kim Hue-Roye; Christine Lomas-Francis; Barbara Gillen; Jennifer Schierts; Kristie Gentzkow; Thierry Peyrard; Inge von Zabern; Willy A Flegel; Karen Rodberg; Asim K Debnath; Soohee Lee; Marion E Reid
Journal:  Transfusion       Date:  2013-04-08       Impact factor: 3.157

4.  When recombinant proteins can replace rare red cells in immunohematology workups.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2021-05-31       Impact factor: 3.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.